ImmunityBio
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ImmunityBio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 159% to $622,000. Profit margin reached -93761%. Total operating expenses were $362,872,000.
Profit Margin
| 2014 | 641K | -6.21M | -969.27% |
|---|---|---|---|
| 2015 | 236K | -236.87M | -100371.19% |
| 2016 | 44K | -120.80M | -274565.91% |
| 2017 | 45K | -96.42M | -214273.33% |
| 2018 | 47K | -96.22M | -204736.17% |
| 2019 | 2.20M | -160.15M | -7273.3% |
| 2020 | 605K | -224.18M | -37055.7% |
| 2021 | 934K | -349.84M | -37456.96% |
| 2022 | 240K | -417.32M | -173883.33% |
| 2023 | 622K | -583.19M | -93761.41% |
IBRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 622K | 240K | 934K | 605K | 2.20M | 47K | 45K | 44K | 236K | 641K |
Cost of revenue | 0 | 24.19M | 0 | 9.14M | 9.01M | 0 | 0 | 0 | 0 | 0 |
Gross profit | 622K | -23.95M | 934K | -8.54M | -6.81M | 47K | 45K | 44K | 236K | 641K |
Operating exp. | ||||||||||
Research and development | 232.36M | 248.14M | 195.95M | 139.50M | 111.99M | 55.71M | 39.77M | 29.15M | 11.43M | 1.59M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | -3.3M | 0 | -1.47M | 0 |
Total operating expenses | 362.87M | 350.85M | 331.21M | 210.82M | 158.45M | 98.43M | 93.59M | 124.54M | 237.64M | 5.92M |
Operating income | -362.25M | -351.29M | -330.28M | -220.88M | -156.25M | -96.29M | -99.12M | -121.31M | -238.87M | -6.21M |
Other income (expenses), net | -221.64M | -65.98M | -19.55M | -25.36M | -4.01M | -433K | 2.20M | -66K | 1.69M | -609K |
Income before tax | -583.89M | -417.28M | -349.83M | -226.03M | -160.26M | -96.72M | -96.91M | -121.38M | -237.17M | -6.21M |
Income tax expense | -40K | 34K | 9K | -1.84M | -105K | -503K | -493K | -572K | -301K | 1K |
Net income | -583.19M | -417.32M | -349.84M | -224.18M | -160.15M | -96.22M | -96.42M | -120.80M | -236.87M | -6.21M |
Earnings per share | ||||||||||
Basic EPS | -1.15 | -1.04 | -0.9 | -0.59 | -0.42 | -0.3 | -1.2 | -0.36 | -3.31 | -0.01 |
Diluted EPS | -1.15 | -1.04 | -0.9 | -0.59 | -0.42 | -0.3 | -1.2 | -0.36 | -3.31 | -0.01 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |